Researchers from UT Arlington suggest that two ruthenium-based complexes can be used to effectively control the growth of cancer cells without overt toxicities caused by traditional chemotherapeutic agents. The results of this study are published in Molecular Cancer Therapeutics.
http://bionews-tx.com/news/2013/05/30/ut-arlington-professor-finds-new-ruthenium-complexes-target-cancer-cells-without-typical-side-effects/
No comments:
Post a Comment